Table 4 Body composition and metabolic variables at baseline and after 8-weeks in the intervention group
| Â | Baseline | 8 weeks | p value |
|---|---|---|---|
Total body fat mass (Kg) | 1.71 ± 0.98 | 3.23 ± 1.70 | 0.004 |
Total body lean mass (Kg) | 25.7 ± 2.7 | 24.8 ± 2.6 | 0.003 |
Percentage fat mass | 5.9 ± 3.3 | 10.8 ± 5.4 | 0.002 |
Trunk fat mass (Kg) | 1.04 ± 0.84 | 2.38 ± 1.45 | 0.004 |
Trunk lean mass (Kg) | 13.3 ± 1.3 | 12.9 ± 1.3 | 0.11 |
Limb fat mass (g) | 489 ± 132 | 626 ± 204 | 0.02 |
Limb lean mass (kg) | 9.8 ± 1.2 | 9.6 ± 1.2 | 0.22 |
Bone mineral content (g) | 1237 ± 122 | 1242 ± 124 | 0.72 |
Fasting glucose (mg/dL) | 95.4 ± 16.6 | 87.6 ± 5.1 | 0.22 |
Fasting insulin (μU/mL) | 18.4 ± 16.1 | 18.9 ± 8.8 | 0.95 |
%Hemoglobin A1c | 4.0 ± 0.3 | 6.0 ± 1.4 | 0.002 |
Total cholesterol (mg/dL) | 103.3 ± 28.7 | 108.2 ± 20.9 | 0.22 |
LDL cholesterol (mg/dL) | 38.0 ± 12.5 | 37.9 ± 14.5 | 0.71 |
HDL cholesterol (mg/dL) | 55.0 ± 17.8 | 48.7 ± 13.7 | 0.42 |
Triglyceride (mg/dL) | 55 ± 13 | 109 ± 67 | 0.006 |
Leptin (ng/mL) | 1.19 ± 1.40 | 3.29 ± 2.32 | 0.001 |
Adiponectin (ng/mL) | 33530 ± 9744 | 23330 ± 7863 | 0.002 |
C-reactive protein (ng/mL) | 53.0 ± 48.8 | 81.5 ± 83.1 | 0.44 |